DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Thursday reported fiscal fourth-quarter net income of $60.3 million.
The Danvers, Massachusetts-based company said it had profit of $1.31 per share. Earnings, adjusted for non-recurring gains and pretax gains, were $1.16 per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.08 per share.
The maker of heart devices posted revenue of $269.9 million in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $267.4 million.
For the year, the company reported profit of $136.5 million, or $2.98 per share. Revenue was reported as $1.03 billion.
Abiomed expects full-year revenue in the range of $1.14 billion to $1.18 billion.
Abiomed shares have decreased 23% since the beginning of the year. The stock has decreased 19% in the last 12 months.
